Early and mid-term outcomes of single-stage laparoscopic sleeve gastrectomy.
BACKGROUND
This is the largest single-centre series of single-stage laparoscopic sleeve gastrectomy (LSG) reporting on perioperative outcomes, weight loss, comorbidity resolution including urological outcomes and results in the super obese. Review of prospectively collected data for patients who underwent LSG from March 2007-August 2009.


METHODS
There were 253 patients with a mean age of 44 years (SD, 9) and a mean preoperative body mass index (BMI) of 50 kg/m(2) (SD, 7). There were 17 (7%) major complications and no deaths. The mean follow-up was 9 months. One hundred and seventy-one patients with a mean follow-up of 12 months had a mean postoperative weight loss of 41 kg (SD, 16) and mean excess BMI (meBMI) loss of 59% (SD, 22).


RESULTS
One hundred fourteen patients were super obese (BMI, >50 kg/m(2)). The mean weight loss was 45 kg (SD, 18), and the meBMI lost was 49% (SD, 21). Super-obese patients experienced more complications (p = 0.02) and lost less eBMI (49% vs. 61%; p < 0.01). Fifty-three patients (46%) remained morbidly obese (BMI, >40 kg/m(2)) postoperatively. Hypertension and diabetes improved or resolved in 73 (79%) and 73 (90%) patients, respectively. Stress urinary incontinence was reported preoperatively in 60 (32%) females, and complete resolution or improvement was reported in 54 (90%) patients.


CONCLUSIONS
LSG provides satisfactory weight loss and resolution of comorbidities in the short- and medium-term with inferior, though acceptable, results in the super obese.
Srinivasa
Sanket
S
Department of Surgery, South Auckland Clinical School, Middlemore Hospital, University of Auckland, Auckland, New Zealand. sanketsri@gmail.com
Hill
Laura S
LS
Sammour
Tarik
T
Hill
Andrew G
AG
Babor
Richard
R
Rahman
Habib
H
D000328:Adult; D005260:Female; D005743:Gastrectomy; D006801:Humans; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D015431:Weight Loss
Obes Surg. 2009 May;19(5):632-40
19184256
Obes Surg. 1997 Dec;7(6):471-7
9730503
Surg Today. 2007;37(4):275-81
17387557
Obes Surg. 2010 May;20(5):535-40
20094819
Obes Surg. 2009 Aug;19(8):1139-42
19484314
Obes Surg. 2009 Oct;19(10):1371-6
19067089
Ann Intern Med. 2005 Apr 5;142(7):547-59
15809466
Obes Res. 2002 Sep;10(9):903-10
12226139
World J Surg. 2008 Jul;32(7):1462-5
18368447
Ann Surg. 2008 Mar;247(3):401-7
18376181
Am J Obstet Gynecol. 1992 Aug;167(2):392-7; discussion 397-9
1497041
Ann Surg. 2005 Oct;242(4):494-8; discussion 498-501
16192809
J Clin Hypertens (Greenwich). 2009 May;11(5):284-8
19490286
Obes Surg. 2010 Mar;20(3):271-5
19997786
J Gastrointest Surg. 2007 Apr;11(4):500-7
17436136
Surg Obes Relat Dis. 2009 Jul-Aug;5(4):469-75
19632646
Surg Obes Relat Dis. 2007 Mar-Apr;3(2):134-40
17386394
Br Med J. 1980 Nov 8;281(6250):1243-5
7427654
Int J Obes Relat Metab Disord. 1998 Mar;22(3):230-5
9539191
Obes Surg. 2007 Feb;17(2):260-70
17476884
Obstet Gynecol. 2005 Dec;106(6):1272-7
16319252
Obes Surg. 2005 Sep;15(8):1124-8
16197783
Obes Surg. 2008 Oct;18(10):1323-9
18535867
Surg Obes Relat Dis. 2005 Nov-Dec;1(6):589-97; discussion 597-8
16925299
Ann Surg. 2004 Aug;240(2):205-13
15273542
World J Surg. 2008 Jun;32(6):939-41
18414942
Obstet Gynecol. 2007 Nov;110(5):1034-40
17978117
Obes Surg. 2006 Feb;16(2):166-71
16469218
Chir Ital. 2009 Mar-Apr;61(2):143-8
19536986
Cir Esp. 2006 Aug;80(2):90-5
16945306
Ann Surg. 2009 Aug;250(2):187-96
19638912
J Intern Med. 1997 Jan;241(1):71-9
9042096
Surg Today. 2008;38(6):481-3
18516524
Obes Surg. 2009 Sep;19(9):1203-10
19572113
Dig Dis Sci. 2007 Apr;52(4):1038-41
17342401
Acta Obstet Gynecol Scand. 2004 Apr;83(4):383-9
15005787
Obes Surg. 2007 Jul;17(7):962-9
17894158
Surg Obes Relat Dis. 2010 Jan-Feb;6(1):1-5
19939744
Obes Surg. 2006 Sep;16(9):1138-44
16989696
Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(1):41-4
10738933